Stock 002900 HARBIN MEDISAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Harbin Medisan Pharmaceutical Co., Ltd.

Equities

002900

CNE1000032V9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
9.92 CNY -0.70% Intraday chart for Harbin Medisan Pharmaceutical Co., Ltd. +0.51% -27.33%
04-26 Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation MT
04-25 Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

HARBIN MEDISAN PHARMACEUTICAL CO LTD is a China-based company principally engaged in the research and development, production and sales of chemical preparations, active pharmaceutical ingredients (APIs), medical devices and cosmetics. Its medicines cover the nervous system, cardio-cerebrovascular, systemic anti-infection, musculoskeletal, nutritional infusion, and body fluid balance infusion therapeutic fields. The Company's products include freeze-dried powder injections, small volume injections, large infusion products, solid preparations, medical devices and cosmetics. The Company mainly distributes its products within domestic market.

Number of employees: 1,721

Sales per Business

CNY in Million2021Weight2022Weight Delta
Freeze Dried Powder Injection
33.9 %
389 41.1 % 348 33.9 % -10.54%
Solid Preparation
24.5 %
172 18.2 % 252 24.5 % +46.28%
Large Transfusion
24.0 %
199 21.1 % 247 24.0 % +23.72%
Small Volume Injection
10.6 %
86 9.1 % 109 10.6 % +26.77%
Import and Export Trade
3.9 %
22 2.3 % 40 3.9 % +81.29%
Other Business
2.0 %
35 3.7 % 20 2.0 % -42.77%
Raw Material
1.0 %
6 0.6 % 11 1.0 % +88.06%
Veterinary Medicine
0.1 %
- - 1 0.1 % -
Medical Device
0.1 %
25 2.6 % 1 0.1 % -97.54%
Feed Additive
0.0 %
- - 0 0.0 % -

Sales per region

CNY in Million2021Weight2022Weight Delta
China
96.1 %
924 97.7 % 988 96.1 % +7.00%
Overseas
3.9 %
22 2.3 % 40 3.9 % +81.29%

Managers

Managers TitleAgeSince
Jian Fei Qin CEO
 Chief Executive Officer 61 13-12-23
Zhi Cheng Zhao DFI
 Director of Finance/CFO 49 21-03-04
Dan Fei Liang BRD
 Director/Board Member 57 13-12-23

Members of the board

Members of the board TitleAgeSince
Fu Sheng Wang BRD
 Director/Board Member 60 19-12-17
Hongquan Liu BRD
 Director/Board Member 65 22-03-16
Jian Fei Qin CEO
 Chief Executive Officer 61 13-12-23
Guo Min Zhu Ge BRD
 Director/Board Member 59 13-12-23
Li Zhou BRD
 Director/Board Member 62 13-12-23
Dan Fei Liang BRD
 Director/Board Member 57 13-12-23
Guo Lin Zeng BRD
 Director/Board Member 45 20-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 323,165,233 104,253,450 ( 32.26 %) 6,775,183 ( 2.097 %) 32.26 %

Shareholders

NameEquities%Valuation
Gfund Management Co., Ltd.
0.0792 %
130,800 0.0792 % 182 424 ¥
China Asset Management Co., Ltd.
0.0384 %
63,500 0.0384 % 88 562 ¥
China Southern Asset Management Co., Ltd.
0.0369 %
61,000 0.0369 % 85 075 ¥
HFT Investment Management Co., Ltd.
0.0214 %
35,400 0.0214 % 49 372 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.0147 %
24,300 0.0147 % 33 891 ¥
China Post & Capital Fund Management Co., Ltd.
0.0132 %
21,800 0.0132 % 30 404 ¥
Essence Fund Co., Ltd.
0.004963 %
8,200 0.004963 % 11 436 ¥
Truvalue Asset Management Co. Ltd.
0.001574 %
2,600 0.001574 % 3 626 ¥
Da Cheng Fund Management Co., Ltd.
0.000968 %
1,600 0.000968 % 2 231 ¥
HuaAn Fund Management Co., Ltd.
0.000545 %
900 0.000545 % 1 255 ¥
NameEquities%Valuation
Dan Fei Liang
0.4173 %
631,600 0.4173 % 880 880 ¥
Zhi Cheng Zhao
0.0661 %
100,000 0.0661 % 139 468 ¥

Holdings

NameEquities%Valuation
HARBIN FUERJIA TECHNOLOGY CO., LTD.
4.97%
 18,000,000 4.97% 77,230,620 $

Company contact information

Harbin Medisan Pharmaceutical Co., Ltd.

Beijing Road Limin Development Zone

150025, Harbin

+

http://www.medisan.com.cn
address Harbin Medisan Pharmaceutical Co., Ltd.(002900)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
HARBIN MEDISAN PHARMACEUTICAL CO., LTD. Stock Harbin Medisan Pharmaceutical Co., Ltd.
-27.33% 424M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002900 Stock
  4. Company Harbin Medisan Pharmaceutical Co., Ltd.